Literature DB >> 809261

Editorial: Considerations of risks versus benefits.

H L Falk.   

Abstract

An evaluation of risks versus benefits from new products should be encouraged, even when dealing with agents which may cause cancer or malformations in laboratory animals, because there is evidence that safety thresholds exist even for such exposures. However, it is not easy to describe risk and benefit in comparable terms when they may involve generations to come and events in the future.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 809261      PMCID： PMC1475201          DOI： 10.1289/ehp.11-1475201

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN： 0091-6765            Impact factor:   9.031


  6 in total

1.  Modification of mutagenesis initiated by ultraviolet light through postteatment of bacteria with basic dyes.

Authors:  E M WITKIN
Journal:  J Cell Comp Physiol       Date:  1961-12

2.  Experimental methods used in determining chronic toxicity; a critical review.

Authors:  J M BARNES; F A DENZ
Journal:  Pharmacol Rev       Date:  1954-06       Impact factor: 25.468

3.  Cancer in the immunosuppressed patient.

Authors:  J L Fahey
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

4.  Asbestos exposure, smoking, and neoplasia.

Authors:  I J Selikoff; E C Hammond; J Churg
Journal:  JAMA       Date:  1968-04-08       Impact factor: 56.272

5.  Defective repair replication of DNA in xeroderma pigmentosum.

Authors:  J E Cleaver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

6.  On the persistence of tumour initiation and the acceleration of tumour progression in mouse skin tumorigenesis.

Authors:  F J Roe; R L Carter; B C Mitchley; R Peto; E Hecker
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.